Mini Review
Accepted on 20 Nov 2025
Patient-Derived Organoids in Non-Small Cell Lung Cancer: Advances in Drug Sensitivity Testing
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
Type at least 3 characters
3,045 articles
Original Research
Published on 20 Nov 2025
Performance of AI-based machine learning models for overall survival prediction in advanced hepatocellular carcinoma patients receiving immunoradiotherapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1719479
- 234 views
Review
Published on 19 Nov 2025
Acute myeloid leukemia drug resistance: targetable nodes and the clinical trajectory of small-molecule inhibitors
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1696229
- 340 views
Original Research
Accepted on 18 Nov 2025
Farrerol Inhibits Proliferation and Migration of Colorectal Cancer via the VEGF Signaling Pathway: Evidence from Network Pharmacology, Molecular Docking, Molecular Dynamics Simulation, and In Vitro Experiments
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
Original Research
Published on 17 Nov 2025
Genetic characterization of pediatric B-cell acute lymphoblastic leukemia in Argentina uncovers molecular heterogeneity and novel variants
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1701680
- 590 views
Editorial
Published on 17 Nov 2025
Editorial: Histone modifications in cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1727417
- 256 views
Review
Accepted on 14 Nov 2025
Efficacy and Safety of Later-Line Targeted Therapies in Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations: A Systematic Review
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
- 669 views
Original Research
Accepted on 14 Nov 2025
Development and validation of a two-dimensional liquid chromatography method for therapeutic drug monitoring of pyrotinib in human plasma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
- 104 views
Review
Accepted on 14 Nov 2025
Flow Cytometric Evaluation of Leukemic Stem Cells in Acute Myeloid Leukemia: Ready for Clinical Diagnostics?
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
Correction
Published on 14 Nov 2025
Correction: Correlation analysis between plasma concentration of nilotinib and clinical efficacy and safety in patients with chronic myeloid leukemia: a single–center retrospective cohort study
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1730637
- 334 views
Review
Published on 13 Nov 2025
Curcumin: biochemistry, pharmacology, advanced drug delivery systems, and its epigenetic role in combating cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1695200
- 565 views
Correction
Published on 13 Nov 2025
Correction: The active constituent of pine needle oil, bornyl acetate, suppresses NSCLC progression by inhibiting the PI3K/AKT/ABCB1 signaling axis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1730938
- 308 views
Original Research
Published on 13 Nov 2025
Multifaced roles of cannabinoid therapy in cancer: balancing analgesia, antitumor potential, and systemic toxicity
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1691893
- 499 views
Original Research
Published on 12 Nov 2025
Eupalinolide A inhibits cancer progression and induces ferroptosis and apoptosis by targeting the AMPK/mTOR/SCD1 signalling in non-small cell lung cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1649314
- 888 views
Review
Accepted on 11 Nov 2025
Navigating Hepatotoxicity of Antibody-Drug Conjugates: From Mechanistic Insights to Clinical and Postmarketing Evidence
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
- 228 views
Systematic Review
Published on 11 Nov 2025
Astragalus polysaccharides combined with radiochemotherapy for cervical cancer: a systematic review and meta-analysis of randomized controlled studies
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1699902
- 511 views